StockWatch
·
Medical/Dental Instruments
Quarterly ResultAug 6, 2026, 03:16 PM

Teleflex Q2 Net Revenue +28.9% to $570.3M; Net Income -18.7% to $99.7M

AI Summary

Teleflex reported Q2 2026 net revenues of $570.3 million, a 28.9% increase from the prior year, while net income decreased by 18.7% to $99.7 million, resulting in diluted EPS of $2.28. For the six months, net revenues rose to $1.12 billion, but net income fell to $91.5 million. The company is undergoing significant strategic divestitures, with the OEM business sale completed in August 2026, and initiated multiple restructuring plans.

Key Highlights

  • Net revenues for Q2 2026 increased 28.9% to $570.3 million from $442.5 million in Q2 2025.
  • Net income for Q2 2026 decreased 18.7% to $99.7 million from $122.6 million in Q2 2025.
  • Diluted EPS for Q2 2026 was $2.28, down from $2.77 in Q2 2025.
  • Six-month net cash provided by continuing operations was $138.6 million, up from $(9.3) million.
  • Completed sale of OEM business on August 3, 2026, as part of strategic divestitures.
  • Entered new Credit Agreement on May 26, 2026, for $1.0B revolving and $1.2B term loan facilities.
  • Initiated Strategic Divestitures restructuring plan with estimated $31M-$37M charges.
  • Long-term borrowings increased to $2.72 billion from $2.54 billion since Dec 31, 2025.